Immortalized bone-marrow derived pig endothelial cells. 2001

J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
Department of Internal Medicine, University Hospital Zürich, Switzerland. klinseeb@usz.unizh.ch

Primary cultures of porcine endothelial cells (EC) can only be maintained for a limited number of passages. To facilitate studies of xenogeneic human anti-pig immune responses in vitro, pig microvascular bone-marrow (BM) and macrovascular aortic EC were obtained from our herd of partially inbred miniature swine, homozygous for the major histocompatibility locus, and immortalized with a modified SV40 large T vector. The resulting BM-derived (2A2) and aortic (PEDSV.15) immortalized EC lines showed unlimited growth and EC phenotype as indicated by expression of von Willebrand Factor (vWF) and low density lipoprotein (LDL) receptors as well as by formation of typical cobblestone monolayers. Ultrastructural studies revealed morphological similarities in primary and immortalized EC. Flow cytometry analysis demonstrated constitutive SLA class I expression by all lines whereas SLA class II was only expressed after stimulation with porcine IFNgamma. Furthermore, pig CD34 mRNA was detected by Northern blot analysis in primary and immortalized aortic EC but not in 2A2. Both EC lines expressed a number of myeloid markers, adhesion molecules and xenoantigens, the latter being determined by binding of human natural antibodies. Gene transfer into the porcine EC lines was successfully performed by electroporation or calcium-phosphate transfection, as well as by adenoviral infection. Finally, the functional similarity between primary and immortalized EC was demonstrated in adhesion and cytotoxicity assays. Together, these results suggest that 2A2 and PEDSV. 15 represent valuable tools to study both human cellular and humoral immune responses in vitro against pig EC derived from microvascular and large vessels.

UI MeSH Term Description Entries
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000952 Antigens, Polyomavirus Transforming Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle. Polyomavirus Large T Antigens,Polyomavirus Middle T Antigens,Polyomavirus Small T Antigens,Polyomavirus T Proteins,Polyomavirus Transforming Antigens,Polyomavirus Tumor Antigens,SV40 T Antigens,SV40 T Proteins,Simian Sarcoma Virus Proteins,Polyomaviruses Large T Proteins,Polyomaviruses Middle T Proteins,Polyomaviruses Small T Proteins,Antigens, Polyomavirus Tumor,Antigens, SV40 T,Proteins, Polyomavirus T,Proteins, SV40 T,T Antigens, SV40,T Proteins, Polyomavirus,T Proteins, SV40,Transforming Antigens, Polyomavirus,Tumor Antigens, Polyomavirus
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D018274 Electroporation A technique in which electric pulses, in kilovolts per centimeter and of microsecond-to-millisecond duration, cause a loss of the semipermeability of CELL MEMBRANES, thus leading to ion leakage, escape of metabolites, and increased uptake by cells of drugs, molecular probes, and DNA. Depending on the dosage, the formation of openings in the cell membranes caused by the electric pulses may or may not be reversible. Electric Field-Mediated Cell Permeabilization,Irreversible Electroporation,Reversible Electroporation,Electropermeabilisation,Electric Field Mediated Cell Permeabilization,Electroporation, Irreversible,Electroporation, Reversible

Related Publications

J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
November 2011, Experimental biology and medicine (Maywood, N.J.),
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
January 1998, In vitro cellular & developmental biology. Animal,
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
July 1998, Blood,
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
January 2016, Methods in molecular biology (Clifton, N.J.),
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
January 2005, EXS,
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
August 2002, Current opinion in molecular therapeutics,
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
July 1963, Journal of anatomy,
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
August 2021, Tissue & cell,
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
June 1998, In vitro cellular & developmental biology. Animal,
J D Seebach, and M K Schneider, and C A Comrack, and A LeGuern, and S A Kolb, and P A Knolle, and S Germana, and H DerSimonian, and C LeGuern, and D H Sachs
January 2004, Journal of cellular and molecular medicine,
Copied contents to your clipboard!